Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition

Ronan Russell(Universität Ulm), Lukas Perkhofer(Universität Ulm), Stefan Liebau(University of Tübingen), Qiong Lin(RWTH Aachen University), André Lechel(Universität Ulm), Fenja M Feld(Universität Ulm), Elisabeth Heßmann(University of Göttingen), Jochen Gaedcke(University of Göttingen), M Güthle(Universität Ulm), Martin Zenke(RWTH Aachen University), Daniel Hartmann(Technical University of Munich), Guido von Figura(TUM Klinikum), Stephanie E. Weissinger(Universität Ulm), K. Lenhard Rudolph(Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)), Peter Mӧller(Universität Ulm), Jochen K. Lennerz(Universität Ulm), Thomas Seufferlein(Universität Ulm), Martin Wagner(Universität Ulm), Alexander Kleger(Universität Ulm)
Nature Communications
July 29, 2015
Cited by 135Open Access
Full Text

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is associated with accumulation of particular oncogenic mutations and recent genetic sequencing studies have identified ataxia telangiectasia-mutated (ATM) mutations in PDAC cohorts. Here we report that conditional deletion of ATM in a mouse model of PDAC induces a greater number of proliferative precursor lesions coupled with a pronounced fibrotic reaction. ATM-targeted mice display altered TGFβ-superfamily signalling and enhanced epithelial-to-mesenchymal transition (EMT) coupled with shortened survival. Notably, our mouse model recapitulates many features of more aggressive human PDAC subtypes. Particularly, we report that low expression of ATM predicts EMT, a gene signature specific for Bmp4 signalling and poor prognosis in human PDAC. Our data suggest an intimate link between ATM expression and pancreatic cancer progression in mice and men.


Related Papers

No related papers found

Powered by citation graph analysis